Key result
Thoracoscopic left cardiac sympathetic denervation reduced the QTc interval from 0.579 s to 0.449 s and prevented further syncopal episodes in a 5-year-old boy with refractory long QT syndrome.
Why the study?
Does thoracoscopic left cardiac sympathetic denervation reduce QTc interval and prevent syncope in a child with refractory long QT syndrome?
Case Report (n=1)
No
Does thoracoscopic left cardiac sympathetic denervation reduce QTc interval and prevent syncope in a child with refractory long QT syndrome?
Thoracoscopic left cardiac sympathetic denervation is a safe and effective treatment for refractory long QT syndrome in children, successfully reducing QTc interval and preventing syncope.
Supports potential role in refractory pediatric LQTS; hypothesis-generating requiring prospective validation.
Long QT syndrome is a cardiac disorder which presents with recurrent syncopal attacks and has risk of sudden cardiac death. A 5-year-old boy presented to us with this syndrome. The child was symptomatic despite medical management and was successfully managed with cardiac denervation. The current report highlights the efficacy and safety of the use of video-assisted thoracoscopic surgery for this procedure.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2019) conducted a case report in Refractory Long QT Syndrome (n=1). Video-assisted thoracoscopic left cardiac sympathetic denervation (LCSD) was evaluated on QTc interval (seconds). Thoracoscopic left cardiac sympathetic denervation reduced the QTc interval from 0.579 s to 0.449 s and prevented further syncopal episodes in a 5-year-old boy with refractory long QT syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: